The Riverside Co. has invested in HemaTerra Technologies, a provider of SaaS-based solutions for independent and hospital-based blood collection centers and plasma collection centers.
The Cleveland-based private equity firm intends to build on HemaTerra’s product offerings by investing in new product development, enhancing sales and marketing, and pursuing strategic partnerships and combinations.
HemaTerra’s family of software products helps customers with donor recruitment and management, online order entry, inventory management, equipment management, quality control tracking, staff scheduling and blood drive scheduling. HemaTerra’s software is used to manage a complex ecosystem of constituents that involves donors, volunteers, collection centers, hospitals and pharmaceutical companies.
Working with Riverside Managing Partner Loren Schlachet and Partner Joe Manning on the deal were Vice President Garrett Monda, Associate Sara Mostatabi, Operating Partner Steve Pogorzelski, Finance Director Mark Pigott and Principal Dan Haynes. Managing Partner Jeremy Holland sourced the deal for Riverside.
